Mezzion Pharma Co.Ltd Capital Reinvestment Ratio

Latest as of September 2023: 1.15x

Mezzion Pharma Co.Ltd capital reinvestment ratio. Mezzion Pharma Co.Ltd (140410) has a Capital Reinvestment Ratio of 1.15x as of September 2023, meaning it reinvests 1% of its operating cash flow (₩4.73 Billion) in capital expenditures (₩5.46 Billion). See free cash flow generation of Mezzion Pharma Co.Ltd to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

1.15x
Capex / Operating Cash Flow

Operating Cash Flow

₩4.73 Billion
KRW

Capital Expenditures

₩5.46 Billion
KRW

Data as of

Sep 2023
Most recent filing

Capital Reinvestment Ratio of Mezzion Pharma Co.Ltd (2012–2015)

Capital reinvestment ratio of Mezzion Pharma Co.Ltd from 2012 to 2015. This chart tracks Mezzion Pharma Co.Ltd's Capital Reinvestment Ratio across 2 annual periods. See Mezzion Pharma Co.Ltd (140410) flexibility index to measure the company's free cash flow as a share of total liabilities.

Mezzion Pharma Co.Ltd Capital Reinvestment Ratio by Year (2012–2015)

Mezzion Pharma Co.Ltd capital reinvestment ratio by year from 2012 to 2015. For the full cash flow conversion analysis, see Mezzion Pharma Co.Ltd cash conversion from operations.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2015 0.32x ₩1.77 Billion ₩564.10 Million ▲ +77.0%
2012 0.18x ₩3.14 Billion ₩564.10 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow